Supreme Court Cases Threaten Abortion Rights and Access

Over 300 researchers and 263 members of Congress urge the court to respect FDA's authority and scientific evidence on mifepristone.

Two Supreme Court cases are currently underway that could significantly impact abortion rights and access in the United States.
One case, Idaho v. United States, questions whether states can disregard federal protections and bar doctors from providing abortions during medical emergencies.
The second case, Alliance for Hippocratic Medicine v. Food and Drug Administration, targets access to mifepristone, a medication used in most abortions and for miscarriage management in the U.S.
If the Supreme Court allows the court of appeals’ order to take effect, it would undo the FDA’s decision to allow patients to obtain mifepristone through telemedicine and by mail.
Over 300 reproductive health researchers and 263 members of Congress have urged the Supreme Court to respect the FDA’s authority and the scientific evidence supporting mifepristone’s safety and effectiveness.